Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 1 of 1 for “"Strensiq"”.

  1. Hypophosphastasia (HPP): pathogenesis and current treatment options

    … the Food and Drug Administration (FDA) approved Strensiq® (asfotase alfa), an enzyme replacement therapy approved for the treatment of patients with perinatal/infantile- and juvenile-onset HPP (3,5). This paper will provide an overview of HPP and current and past treatment options for HPP, …

    bu Repository record for Hypophosphastasia (HPP): pathogenesis and current treatment options (opens in a new tab)